With high volumes continuing to present to UHL, these restrictions, while regrettable for patients and their loved ones, have been deemed necessary in the interests of patient care. All infection control measures are in place and every effort is being made to manage the situation with CPE-positive patients and CPE contacts being isolated and cohorted as appropriate.
A number of measures have been taken to deal with the current outbreak. These include
– twice weekly incident meetings convened for all affected areas
– isolation of all positive patients with strict high level contact precautions
– All CPE contacts are screened for a period of 28 days with 4 negative swabs. These patients are isolated/cohorted with contact precautions
– Extensive environmental cleaning and hydrogen peroxide decontamination is underway
CPE is recognised as being endemic in the MidWest Region and UL Hospitals Group has developed comprehensive control measures to deal with Multi-Drug Resistant Organisms.
UL Hospitals Group is proactive in screening patients for CPE in line with national and international best practice and guidance. This helps identify at risk colonised patients asymptomatically carrying CPE, allowing for the appropriate control measures to be put in place. Screening protocols that have been in place at UHL for a number of years have been the template for the development of the national screening policy for the National Public Health Emergency Team on CPE.
There has been strengthened governance in relation to CPE across the UL Hospital Group including the establishment of a CPE Strategic Committee. Information on CPE is shared with senior management and clinicians and escalated nationally through the appropriate channels.